NICNAS Reforms Treatment of Confidential Commercial Information Workshop.

Slides:



Advertisements
Similar presentations
Solvency ii: an overview Lloyds May © LloydsSolvency II May Contents Solvency II: key features Legislative process Solvency II implementation.
Advertisements

The Legislative Position in Scotland Environmental Information (Scotland) Regulations 2004 SSI 2004 No.520 Professor Colin Reid, School of Law, University.
1.04 Patient Rights Legislation
Infrastructure Planning Commission Workshop 2b Working with the IPC: Guidance and issues for promoters.
Confidentiality and HIPAA
1 INTRODUCTION What is Happening with REACH Hong Kong
Toxic Substances Control Act TSCA Current Events Heighten Awareness for Semiconductor Industry SESHA Hill Country Chapter December 5, 2002.
Paola Lucantoni Financial Market Law and Regulation.
2009 ICN Merger Workshop Maria Coppola Tineo Taipei, Taiwan March 9, 2009 Session 1. Merger Notification and Initial Review.
Data-Sharing and Governance Consultation ANALYSIS OF RESPONSES.
Code of Federal Regulations Title 42, Chapter 1, Subchapter A Part 2 – CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENTS BRYANT D. MILLER CAC II, MAC,
The Revision of the Waste Framework Directive Key suggested amendments by the Rapporteur.
ISO 9001 Interpretation : Exclusions
Australia’s Experience in Utilising Performance Information in Budget and Management Processes Mathew Fox Assistant Secretary, Budget Coordination Branch.
OSHA Long Term Care Worker Protection Program.  Recognize the purpose of the hazard communication standard.  Describe the components of a hazard communication.
1 Consent for treatment A summary guide for health practitioners about obtaining consent for treatment Bridie Woolnough Resolution Officer Health Care.
Towards a Freedom of Information Law in Qatar Fahad bin Mohammed Al Attiya Executive Chairman, Qatar National Food Security Programme.
Implementation of Security and Confidentiality in GP Practices.
1 Discussion of the 2006 Inventory Update Reporting Data December 12, 2006 Nhan Nguyen U.S. EPA.
SSSG 2007 Global Harmonization System. What is GHS ? GHS is an international system designed to standardize the communication of hazardous substances.
1 Acquisition, Relocation and Displacement For Local Officials.
Limited Proceedings Water & Wastewater Reference Manual1.
The Policy Company Limited © Control of Infection.
Code Administrators Working Group Introduction 28 August 2008.
Best Practices: Where Industry Should Lead on Ensuring Proper Testing & Auditing Stephen F. Sundlof, DVM, PhD Senior Advisor for Animal and Food Safety.
HIT Standards Committee Privacy and Security Workgroup: Initial Reactions Dixie Baker, SAIC Steven Findlay, Consumers Union June 23, 2009.
Authorisation of medicinal products: selected challenges Rocío Salvador Roldán Pharmaceuticals Unit/DG SANCO This presentation only reflects the views.
Chapter 10 – Dissemination Ilaria Dimatteo United Nations Statistics Division The 4 th meeting of the Oslo Group on energy statistics Ottawa, Canada, 2-6.
ISO 9001:2008 to ISO 9001:2015 Summary of Changes
An agency of the European Union Presented by: Emer Cooke and Truus Janse-de Hoog Update on Transparency Progress report from HMA/EMA TF on Transparency.
& H AS HEALTH AND SAFETY AUTHORITY REACH and Downstream Users Marie McCarthy REACH GI Inspector Health and Safety Authority.
Foreign Supplier Verification Programs Supplemental Proposal 1.
OPEN UP! Introduction to handling Freedom of Information requests.
Association of Childrens Welfare Agencies Conference 2006 Improving Care Through Accreditation- The Role of the NSW Children’s Guardian.
EPA essential principles for reform of chemicals management legislation – lessons from REACH Dr Veerle Heyvaert London School of Economics Chemical Regulation:
Malaysia Update on “draft” proposal for the Environmentally Hazardous Substance (“EHS”) Notification and Registration Scheme.
1 Proposed amendments to the National Environmental Management Act, 1998 (NEMA) October 2007 Presentation by Joanne Yawitch DDG EQP.
Governance and Charging Methodology for User Pays Services 10 th January 2007.
SPS Workshop Taipei, 5-6/12/2001 The Transparency Provisions of the SPS Agreement.
Alison Elstone IWS Proposed Changes to Legislation and it’s Effect on Irish Water Safety Vetting Policy Alison Elstone IWS
NICNAS Reforms Consultation Paper 1. Purpose of workshop Explaining Consultation Paper 1 and seeking your input. Gathering information to inform Consultation.
Copyright © 2015 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 3 Privacy, Confidentiality, and Security.
HIPAA Vs. Family Educational Rights and Privacy Act (FERPA) How do these laws impact Educational Settings?
Support and aspiration: A new approach to special educational needs and disability A consultation March 2011.
ECB INFODAYS, Zagreb, Croatia, December 2006 EU Notification Scheme (New Substances) and New Chemicals Database ECB INFODAYS, Zagreb, December.
HIPAA Privacy Rule Positive Changes Affecting Hospitals’ Implementation of the Rule.
Special Meeting on Procedures for Information Exchange November 7, 2007 Geneva Session 1 Anne Meininger United States USA WTO TBT Enquiry Point.
Public Consultation Session: Consultation and Transparency Requirements for Offshore Petroleum Activities Francesca Astolfi A/g General Manager, Offshore.
November 2012 Briefing on exposure draft Human Rights and Anti- Discrimination Bill.
NICNAS Reforms Consultation Paper 2. Overview of NICNAS Reforms Summary of consultation process and outcomes New approaches in Consultation Paper 2 Workshop.
The new chemicals risk matrices. Workshop focus use of new online categorisation tools criteria used to categorise new chemicals under the proposed framework.
“EMA policy on publication of Clinical Data” 27/11/2014SFdS - Journée Annuelle du groupe Biopharmacie & Santé.
Freedom of Information Act ‘What you need to know’ Corporate Information Governance Team Strategic Intelligence.
NICNAS Reforms Community Stakeholder Workshop. Input from non-industry stakeholders on NICNAS Reforms Working within parameters of Government decision.
HIPAA Privacy Rule Positive Changes Affecting Hospitals’ Implementation of the Rule Melinda Hatton -- Oct. 31, 2002.
Data Protection Officer’s Overview of the GDPR
The Protection of Confidential Commercial or Industrial Information in Environmental Law: Analysis and Call for a Graded Concept of Protection Prof. Dr.
Statewide Rule 29 and FracFocus
1.04 Patient Rights Legislation
1.04 Patient Rights Legislation
Changes to Exempt Categories
Outcome TFCS-11// February Washington DC
Irish Retail Market Assurance
Changes to Exempt Categories
CMC_02_18 Permitted Disclosures – Credit Agencies
Assignment 2 Learning Aim D: Individual Treatment Plan
Final Rule on Foreign Supplier Verification Programs
1.04 Patient Rights Legislation
Children and Families Act 2014
Presentation transcript:

NICNAS Reforms Treatment of Confidential Commercial Information Workshop

To provide an overview of: current protection of CCI objectives of proposed changes to CCI options under consideration Purpose of the workshop

The most appropriate way to protect CCI while ensuring transparency and availability of assessment information to the public and workers We seek your advice

Improve: - transparency -usefulness of assessment information Maintain protections for information that is genuinely CCI Align internationally where possible Enable information (including CCI) to be provided to risk managers Objectives of reforms

Application - to have information treated as exempt (from publication) Test – publishing information could reasonably be expected to prejudice substantially the commercial interests of the applicant, and that this prejudice outweighs the public interest with respect to publishing that information Basic information - cannot be exempt information (e.g. known name, general use, precautions and restrictions, recommendations, emergency procedures, certain physical and chemical data, certain data re health and environmental effects) Current approach – Exempt information

Chemical identity Market information – exact introduction volumes Specifics of use – including function of the chemical in a product, exact concentrations, detailed operation descriptions Polymer details – molecular weight, monomer ratios and polydispersity Commonly requested exempt information

Application - to have the chemical added to confidential AICS Test – As for exempt information Disclosure - Presence on AICS disclosed only to those with bona fide intent to introduce Review - Inclusion on confidential AICS reviewed every 5 years Current approach – Confidential AICS

Current treatment of CCI Notifier can apply for certain information to be exempt from publication Statutory test Publish assessment with/without exempt information Notifier can apply for listing on Confidential AICS Statutory test Publish chemical on the public or confidential AICS Reviewed: 5 yearly using same test Disclosure: bona fide introduction Commercial interest VS public interest Confidential indefinitely

Publishing information options Current publication requirementsProposed publication requirements Exempt Chemicals - Summary published annually Exempted -No requirements Permits - List of permits published annually Reported -No requirements Assessment certificates - Assessment report published Assessed - Assessment Statement published (including Exempted/Reported chemicals assessed by NICNAS) NICNAS assessment (PEC, IMAP, secondary notification) - Assessment report published NICNAS initiated assessment - Assessment Statement published AICS - CAS number, chemical name, molecular formula, associated name, conditions of use (if any), statement if secondary notification applies AICS - CAS number, chemical name, molecular formula, associated name, defined assessment scope, conditions of use (if any), link to Assessment Statement

Limitations of existing approach Does not address Government objectives: No public information available for chemicals on the Confidential AICS Undermines public confidence Unusual situation – introducers advised of confidential listing but unable to access risk assessment information No linking of assessment report to chemical on public AICS Limits transparency and reduces meaningfulness for consumers, workers and others

Only circumstances NICNAS will publicly release information about a chemical - publication of an Assessment Statement - entries on AICS - to a bona fide enquirer Less information published Will link assessed AICS chemical to Assessment Statement Proposed approach

Four proposals under consideration 1. Masking chemical names 3. CCI protections for other information ? 4. Full disclosure to Government risk managers Any other options that meet objectives? 2. Generalising use/scope description

Feedback from CP1: Mixed support Application – To remove/make generic one or more components of chemicals name Test – Commercial and public interest Outcome – Agreed masked name for all publication purposes (Assessment Statement and for AICS) Advantages and disadvantages of this approach? Implementation issues? Period of masking? Impact of disclosure of name in other countries? Is confidential AICS still needed? Proposal 1 - Masked names

Fully defined name (no masking) Reaction product of 3,5-di-tert-butyl-2-hydroxybenzoic acid and aluminium sulfate Single masking Reaction product of 3,5-di-tert-butyl-2-substituted-benzoic acid and aluminium sulfate (masking the hydroxy group) Reaction product of di-tert-butyl-2-hydroxybenzoic acid and aluminium sulfate (deleting a set of position numbers) Double masking Reaction product of di-tert-butyl-carboxyl-hydroxy-arene and aluminium sulfate (deleting all position numbers and masking parent structure) Masking Names (Example 1)

Fully defined name (no masking) 6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol Single masking 6,9-bis(hexadecyloxymethyl)-4,7-dioxanonanetriol (deleting the “1,2,9-”) 6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-trisubstituted (masking the triol group) 6,9-bis(hexadecyloxymethyl)-4,7-dioxaalkane-1,2,9-triol (masking the parent structure) Double masking bis(hexadecyloxymethyl)dioxaalkanetriol (deleting all position numbers, and masking parent structure) Masking Names (Example 2)

Common features of international masked name regimes: minimum level of masking used to protect CCI all chemicals are on the public inventory some chemical identity information available despite masking enables identification of published assessment information Additional justification required for double or greater masking International use of masked names

Application - For generalised scope/use description Test – Commercial and public interest Outcome – A generalised scope/use description for all publication purposes (Assessment Statement and for AICS) Advantages and disadvantages of this approach? Implementation issues? Proposal 2 – Application to generalise scope/use

Specific useGeneralised use Dispersant ingredient in a paint at 6% to be applied to structures such as bridges Industrial surface coatings up to 10% concentration Viscosifier in drilling fluids at a concentration of 4.5 kg per cubic metre of drilling fluid, introduced at 33 tonnes per annum Additive in drilling fluid at a concentration of < 5 kg per cubic metre of drilling fluid, introduced at up to 50 tonnes per annum Generalised use examples

Is there other information that: is not basic information is not the chemical name or use would otherwise be published by NICNAS but could require protection? Proposal 3 – Any other information that may require protection

New legislative provision authorising NICNAS to release information to government risk management agencies Will include provisions to ensure confidentiality is maintained by the receiving agencies Proposal 4 – Disclosure to risk managers

Have your say

More information: